Aesthetics is one of the fastest growing segments within the medical
device industry. A facial aesthetic device is a kind of device used for
skin treatment to aesthetically improve the structure of facial tissue.
Facial aesthetic devices can work through an invasive mechanism or a
minimally invasive mechanism. Currently, the trend of using minimally
invasive devices is on the rise, due to advancements in the technology
of aesthetic devices. Health concerns and rise in demand for
technologically advanced products drives the growth of the global
medical aesthetics devices market.
Increase in demand for minimally invasive and non-invasive procedures
such as skin rejuvenation, facial aesthetic devices, microdermabrasion,
and others; less recovery time of the procedure; fewer chances of
post-surgical complications; rise in GDP of developing economies;
increase in the number of dermatological and other beauty clinics with
improved infrastructure; and increase in medical tourism are some of the
major factors contributing to the growth of the facial aesthetic
devices market. However, unfavorable reimbursement policies, competitive
pricing and equipment costs, and low availability of experienced
surgeons to perform procedures with facial aesthetic devices in
developing countries are some of the factors hindering the growth of the
facial aesthetic devices market.
The global facial aesthetic devices market can be segmented based on
type, end-user, and region. Based on type, the global facial aesthetic
devices market can be classified into microdermabrasion devices,
botulinum toxin, dermal fillers, threads, and others. The botulinum
toxin and dermal fillers segments constitute a major share of the facial
aesthetic devices market, owing to increased demand for dermal fillings
fuelled by people’s desire to look good. In terms of end-user, the
global facial aesthetic devices market can be categorized into
dermatology clinics and hospitals and recreation centers. The
dermatology clinics segment is expected to constitute significant market
share during the current year and is also expected to dominate the
facial aesthetic devices market in the near future. Availability of
customized services, customer service satisfaction, and increase in the
number of dermatology clinics providing facial aesthetic devices
treatment and a combination treatments are major factors boosting the
segment.
In terms of region, the global facial aesthetic devices market can be segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America is estimated to be a prominent region of the facial aesthetic devices treatment market because of the availability of customized treatment due to advancements in technology, rise in the importance of aesthetic appearance, increase in advanced health care infrastructure facilities, and availability of many experienced dermatologists and cosmetic surgeons to perform the facial aesthetic devices procedures. The facial aesthetic devices market in Europe is expected to expand during the forecast period due to an increase in health concerns. In terms of revenue, Germany and the U.K. are leading countries of the facial aesthetics devices market in Europe. The facial aesthetic devices market in Asia Pacific is likely to expand at a robust pace in the coming years, owing to an increase in the patient population, a rise in awareness about aesthetic solutions, and advancements in health care services.
Major players operating in the facial aesthetic devices market are Allergan plc, Valeant Pharmaceuticals, Johnson & Johnson, Syneron Medical Ltd., Lumenis Ltd.,Galderma, Glytone, Contura, IMAGE SKINCARE, Cynosure Inc., Merz Pharma GmbH & Co. KGaA, Ipsen Pharmaceuticals, Merz Pharma, Anika Therapeutics, Sinclair Pharma, GC Aesthetics plc, Sientra Inc., Shanghai Fosun Pharmaceutical (Group) Co. Ltd., Zimmer Inc., La Roche-Posay, Hangzhou Techderm Biological Products, and others.
In terms of region, the global facial aesthetic devices market can be segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America is estimated to be a prominent region of the facial aesthetic devices treatment market because of the availability of customized treatment due to advancements in technology, rise in the importance of aesthetic appearance, increase in advanced health care infrastructure facilities, and availability of many experienced dermatologists and cosmetic surgeons to perform the facial aesthetic devices procedures. The facial aesthetic devices market in Europe is expected to expand during the forecast period due to an increase in health concerns. In terms of revenue, Germany and the U.K. are leading countries of the facial aesthetics devices market in Europe. The facial aesthetic devices market in Asia Pacific is likely to expand at a robust pace in the coming years, owing to an increase in the patient population, a rise in awareness about aesthetic solutions, and advancements in health care services.
Major players operating in the facial aesthetic devices market are Allergan plc, Valeant Pharmaceuticals, Johnson & Johnson, Syneron Medical Ltd., Lumenis Ltd.,Galderma, Glytone, Contura, IMAGE SKINCARE, Cynosure Inc., Merz Pharma GmbH & Co. KGaA, Ipsen Pharmaceuticals, Merz Pharma, Anika Therapeutics, Sinclair Pharma, GC Aesthetics plc, Sientra Inc., Shanghai Fosun Pharmaceutical (Group) Co. Ltd., Zimmer Inc., La Roche-Posay, Hangzhou Techderm Biological Products, and others.
No comments:
Post a Comment